TENAYA THERAPEUTICS GRANTED U.S. FDA REGENERATIVE MEDICINE ADVANCED THERAPY (RMAT) DESIGNATION FOR TN-401 FOR THE TREATMENT OF PKP2-ASSOCIATED ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY

Reuters · 2d ago

Please log in to view news